Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

GSK Investigational Site, New York

GSK Investigational Site, Poughkeepsie

GSK Investigational Site, Carnegie

GSK Investigational Site, Pleasant Hills

GSK Investigational Site, Erie

GSK Investigational Site, Erie

GSK Investigational Site, Philadelphia

GSK Investigational Site, Philadelphia

GSK Investigational Site, Charlottesville

GSK Investigational Site, Chapel Hill

GSK Investigational Site, New Bern

GSK Investigational Site, Miami

GSK Investigational Site, West Palm Beach

GSK Investigational Site, Clearwater

GSK Investigational Site, Bardstown

GSK Investigational Site, Louisville

GSK Investigational Site, Cleveland

GSK Investigational Site, Iowa City

GSK Investigational Site, Minneapolis

GSK Investigational Site, Arkansas City

GSK Investigational Site, Newton

GSK Investigational Site, Wichita

GSK Investigational Site, Omaha

GSK Investigational Site, Tulsa

GSK Investigational Site, Houston

GSK Investigational Site, Webster

GSK Investigational Site, Austin

GSK Investigational Site, Louisville

GSK Investigational Site, Denver

GSK Investigational Site, Albuquerque

GSK Investigational Site, San Diego

GSK Investigational Site, San Francisco

GSK Investigational Site, Honolulu

GSK Investigational Site, Portland

GSK Investigational Site, Wenatchee

GSK Investigational Site, Spokane

GSK Investigational Site, Augusta

GSK Investigational Site, Lebanon

GSK Investigational Site, Morristown

GSK Investigational Site, Edmonton

GSK Investigational Site, Langley

GSK Investigational Site, Winnipeg

GSK Investigational Site, St. John's

GSK Investigational Site, Truro

GSK Investigational Site, Waterloo

GSK Investigational Site, Beauport

GSK Investigational Site, Gatineau

GSK Investigational Site, Montreal